Covalon Technologies Ltd (COV):企業の財務・戦略的SWOT分析

◆英語タイトル:Covalon Technologies Ltd (COV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME7222FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound care products include collagen matrix dressing, collagen matrix dressing with silver, wound contact layer, non-adherent foam dressing and superabsorbent dressing, among others. Its infection prevention products comprise antimicrobial clear silicone adhesive dressing with chlorhexidine and silver; antimicrobial self-adherent silicone film drape for preoperative skin with chlorhexidine and silver; silicone foley catheter, and others. The company also develops and commercializes proprietary technologies in the areas of advanced wound care, cardiology, urology, vascular access, orthopaedics and surgery, among others. Covalon is headquartered in Mississauga, Ontario, Canada.

Covalon Technologies Ltd Key Recent Developments

Mar 01,2021: Covalon announces first quarter fiscal 2021 results
Jan 28,2021: Covalon announces fiscal 2020 year-end results
Nov 13,2020: Covalon announces appointment of Amir Boloor as Board Chair and voting results from fiscal 2019 annual and special meeting of shareholders
Aug 24,2020: Covalon announces third quarter fiscal 2020 results
Jul 14,2020: Covalon announces second quarter fiscal 2020 results

This comprehensive SWOT profile of Covalon Technologies Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Covalon Technologies Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Covalon Technologies Ltd – Key Information
Covalon Technologies Ltd – Overview
Covalon Technologies Ltd – Key Employees
Covalon Technologies Ltd – Key Employee Biographies
Covalon Technologies Ltd – Key Operational Heads
Covalon Technologies Ltd – Major Products and Services
Covalon Technologies Ltd – History
Covalon Technologies Ltd – Company Statement
Covalon Technologies Ltd – Locations And Subsidiaries
Covalon Technologies Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Covalon Technologies Ltd – Business Description
Covalon Technologies Ltd – Corporate Strategy
Covalon Technologies Ltd – SWOT Analysis
SWOT Analysis – Overview
Covalon Technologies Ltd – Strengths
Covalon Technologies Ltd – Weaknesses
Covalon Technologies Ltd – Opportunities
Covalon Technologies Ltd – Threats
Covalon Technologies Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Covalon Technologies Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Covalon Technologies Ltd, Key Information
Covalon Technologies Ltd, Key Ratios
Covalon Technologies Ltd, Share Data
Covalon Technologies Ltd, Major Products and Services
Covalon Technologies Ltd, History
Covalon Technologies Ltd, Key Employees
Covalon Technologies Ltd, Key Employee Biographies
Covalon Technologies Ltd, Key Operational Heads
Covalon Technologies Ltd, Other Locations
Covalon Technologies Ltd, Subsidiaries
Covalon Technologies Ltd, Key Competitors
Covalon Technologies Ltd, SWOT Analysis
Covalon Technologies Ltd, Ratios based on current share price
Covalon Technologies Ltd, Annual Ratios
Covalon Technologies Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Covalon Technologies Ltd (COV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BrainLAB AG:企業の戦略的SWOT分析
    BrainLAB AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Human Longevity Inc-製薬・医療分野:企業M&A・提携分析
    Summary Human Longevity Inc (HLI) is a genomics-based, technology-driven company which develops database of whole genome, phenotype and clinical data. Its discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomark …
  • Bureau Veritas SA (BVI)-エネルギー分野:企業M&A・提携分析
    Summary Bureau Veritas SA (Bureau Veritas) is a testing, inspection and certification service provider that offers varied services such as asset management, certification, classification, consulting, inspection and audits, testing and analysis, and training. The company serves aeronautics, agricultu …
  • Scholastic Corp (SCHL):企業の財務・戦略的SWOT分析
    Scholastic Corp (SCHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • State Oil Company of Azerbaijan Republic:企業のM&A・事業提携・投資動向
    State Oil Company of Azerbaijan Republic - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's State Oil Company of Azerbaijan Republic Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • Fisia Italimpianti SpA:企業の戦略的SWOT分析
    Fisia Italimpianti SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bounty Oil & Gas NL (BUY):企業の財務・戦略的SWOT分析
    Bounty Oil & Gas NL (BUY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • GRI Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary GRI Bio Inc (GRI Bio) is a biotech company that develops and manufactures therapies for inflammatory diseases. The company develops Natural Killer T cell based therapies for the treatment of liver disease and autoimmune disoders. Its lead candidate GRI-0621, a novel oral therapeutic for live …
  • Lloyds Banking Group Plc:企業のM&A・事業提携・投資動向
    Lloyds Banking Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lloyds Banking Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • HemaCare Corp (HEMA)-医療機器分野:企業M&A・提携分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, bone marrow and cord blood. It spans its expertise in isolations, custom cell collections and testing of pr …
  • Abaxis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abaxis Inc (Abaxis) is a provider of technology, tools and services for wide range of medical applications for human and veterinary patient-care. The company focuses on development, manufacture, and marketing of portable blood analysis systems. Its portfolio encompasses patented products inc …
  • New Jersey Resources Corp (NJR):企業の財務・戦略的SWOT分析
    New Jersey Resources Corp (NJR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Pierre & Vacances SA (VAC):企業の財務・戦略的SWOT分析
    Pierre & Vacances SA (VAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • AccentCare Inc:企業の戦略的SWOT分析
    AccentCare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Electricite de France SA (EDF)-エネルギー分野:企業M&A・提携分析
    Summary Electricite de France S.A. (EDF) is a state-owned integrated energy company that generates, transmits, distributes and sells electricity; supplies natural gas; and offers energy services such as district heating, thermal energy services and other services. The group generates electricity fro …
  • Spark New Zealand Ltd:企業の戦略・SWOT・財務情報
    Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report Summary Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • L’Occitane International SA:企業の戦略・SWOT・財務情報
    L'Occitane International SA - Strategy, SWOT and Corporate Finance Report Summary L'Occitane International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • United International Enterprises Limited:企業の戦略・SWOT・財務分析
    United International Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary United International Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Esperion Therapeutics Inc (ESPR)-製薬・医療分野:企業M&A・提携分析
    Summary Esperion Therapeutics Inc (Esperion) is a pharmaceutical company that develops and commercializes oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). The company’s lead product candidate, Bempedoic acid, an ATP-citrate lyase inhibitor which is in Phase …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆